# A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER

> **NCT07515950** · — · NOT_YET_RECRUITING · sponsor: **MedSIR** · enrollment: 244 (estimated)

## Conditions studied

- Biliary Tract Cancer (BTC)

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT07515950
- **Lead sponsor:** MedSIR
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2027-05
- **Final completion:** 2027-07
- **Target enrollment:** 244 (ESTIMATED)
- **Last updated:** 2026-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07515950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07515950, "A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07515950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
